Form BRD-1 Business R&D Survey

Attachment A
U.S. DEPARTMENT OF COMMERCE
U.S. CENSUS BUREAU
FORM

BRD-1 (07-03-2024)

2024 BUSINESS ENTERPRISE RESEARCH
AND DEVELOPMENT SURVEY
OMB No. 0607-0912: Approval Expires 12/31/2024

DUE DATE:

Need help or have
questions about filling
out the form?
Visit https://www.census.gov/
programs-surveys/brds/
information.html
Here, you can access
question-by-question detailed
instructions and learn more
about the survey.

Call toll-free 1-800-416-3262,
between 8:00 a.m. and
8:00 p.m. Eastern time,
Monday through Friday.

(Please correct any errors in this mailing address)

Please file your form electronically at:
https://portal.census.gov
Authentication Code:

YOUR RESPONSE IS REQUIRED BY LAW. Title 13, United States Code, Sections 8(b), 131, and 182,
and Title 42, United States Code, Sections 1861-76 (National Science Foundation Act of 1950, as
amended), and Section 505 within the America COMPETES Reauthorization Act of 2010 authorize this
collection. Sections 224 and 225 of Title 13 require your response. The U.S. Census Bureau is required
by Section 9 of Title 13 to keep your information CONFIDENTIAL and can use your responses only to
produce statistics. The Census Bureau is not permitted to publicly release your responses in a way that
could identify your business, organization, or institution. Per the Federal Cybersecurity Enhancement
Act of 2015, your data are protected from cybersecurity risks through screening of the systems that
transmit your data.
THIS COLLECTION HAS BEEN APPROVED by the Office of Management and Budget (OMB). The
eight-digit OMB approval number is 0607-0912 and appears at the upper right corner of this page.
Without this approval, we could not conduct this survey.
We estimate this survey will take an average of 2 hours and 37 minutes to complete. More information
about this estimate and an email address where you may write with comments is on the back of this
form.
THANK YOU – YOUR RESPONSE IS IMPORTANT. Accurate and timely statistical information could
not be produced without your cooperation and goodwill. Thank you.
∼ This survey is jointly conducted by the U.S. Census Bureau and the National Center for Science and
Engineering Statistics (NCSES) within the National Science Foundation. ∼

Table of Contents
This survey is divided into seven sections based on subject matter. You may need to collaborate with
colleagues in different departments to complete all sections. The following table of contents summarizes
the subject matter covered by each section and what is required to complete them.

Section 1: Company Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . p.4
Topics include company ownership, business activities, revenues, and employees.

Section 2: R&D Paid For by Your Company . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . p.8
Topics include geographic location and accounting details related to R&D expenses.

Section 3: Costs Paid For by Others . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . p.19
Topics include customer-sponsored work and activities funded through grants and/or reimbursements.

Section 4: Assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . p.33
Topics include stock of capital, both tangible and intangible, your company owned and acquired.

Section 5: Management and Strategy of R&D . . . . . . . . . . . . . . . . . . . . . . . . . . . . p.36
Topics include characteristics of R&D reported in Sections 2 and 3. Requires familiarity with the
technical and strategic aspects of your company’s R&D.

Section 6: Human Resources . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . p.41
Topics include your company’s employees, focusing on those who work on R&D activities.

Section 7: Intellectual Property and Technology Transfer . . . . . . . . . . . . . . . . . . p.49
Topics include patenting, licensing, and other technology transfer activities.

Section 8: Tax Topics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . p.52
Topics include state and federal tax credits applied for by your company.

Changes from the 2023 survey
Questions related to detail of R&D performed by others, as well as activities with academia were removed from Section
2. Questions related to industry of business and specific federal agency funding R&D were removed from Section 3.
Questions related to details of assets owned or leased were removed from Section 4. Questions that asked for
percentage of R&D with specific application areas were removed from Section 5. Questions related to Intellectual
Property and Technology Transfer were reintroduced to Section 7.For a list of specific changes go to

https://www.census.gov/programs-surveys/brds/about/faq.html.

Electronic materials
Electronic versions of the questionnaire and related information are available at
https://www.census.gov/programs-surveys/brds/information.html.
Available materials include:
● PDF copy of the questionnaire
● Excel worksheets for each section that can be completed and uploaded
● Question-by-question instructions, definitions, and examples that provide clarification
● Answers to frequently asked questions, including how the data will be used

Filing electronically
Filing electronically via our secure website allows you to save the data as you go, so you can exit and
resume later where you left off. It also allows you to save an electronic copy of your completed survey.
To submit online, follow the instructions at
https://www.census.gov/programs-surveys/brds/information.html.

Form BRD-1

2

What is Research and Development (R&D)?
Research and development (R&D) comprise creative and systematic work undertaken in order to increase
the stock of knowledge and to devise new applications of available knowledge. This includes: a) activities
aimed at acquiring new knowledge or understanding without specific immediate commercial applications
or uses (basic research); b) activities aimed at solving a specific problem or meeting a specific commercial
objective (applied research); and c) systematic work, drawing on research and practical experience and
resulting in additional knowledge, which is directed to producing new products or processes or to
improving existing products or processes (development). R&D includes both direct costs such as salaries
of researchers as well as administrative and overhead costs clearly related to the company’s R&D.
The term R&D does NOT include expenditures for:
● Costs for routine product testing, quality control, and technical services unless they are an integral
part of an R&D project
● Market research
● Efficiency surveys or management studies
● Literary, artistic, or historical projects, such as films, music, or books and other publications
● Prospecting or exploration for natural resources

Does R&D include development of software and Internet applications?
Research and development activity in software and Internet applications refers only to activities with
an element of uncertainty and that are intended to close knowledge gaps and meet scientific and
technological needs. Report in this survey all software R&D as defined here regardless of the eventual
user (internal or external).
R&D activity in software INCLUDES:
● Software development or improvement activities that expand scientific or technological knowledge
● Construction of new theories and algorithms in the field of computer science
R&D activity in software EXCLUDES:
● Software development that does not depend on a scientific or technological advance, such as
● supporting or adapting existing systems
● adding functionality to existing application programs, and
● routine debugging of existing systems and software
● Creation of new software based on known methods and applications
● Conversion or translation of existing software and software languages
● Adaptation of a product to a specific client, unless knowledge that significantly improved the base
program was added in that process

Reporting unit
The reporting unit is your company, including all majority-owned subsidiaries regardless of location.
Majority ownership is defined as more than 50 percent ownership. For reporting purposes, exclude
data for any companies that are minority-owned by your company. If your company is majority-owned
by a company located outside the 50 United States and D.C. (foreign parent), the reporting unit for the
survey is only your U.S.-located company, including all its majority-owned subsidiaries regardless of
location. For reporting purposes, your foreign parent and any foreign affiliates your company does not
own should be treated the same as any business partner, customer, or supplier you do not own.

Reporting period
Report data for the calendar year 2023, if possible, or for your company’s fiscal year ending between
April 2023 and March 2025.

Estimates are acceptable
Please report all items to the best of your ability.

To speak with a survey specialist, call 1-800-416-3262.
Survey specialists are available Monday through Friday, from 8:00 a.m. to 8:00 p.m. Eastern time, to help
with any questions you may have.

Form BRD-1

3

SECTION 1

SECTION 1
Company Information
1-1

Has your company ceased operations?
Yes ➔ Please provide the following information:
(MM)

(DD)

(YYYY)

Date your company ceased operations
REPORTING INSTRUCTIONS:
If your company ceased operations on or after April 1, 2023, report only for the period January 1,
2023 to the date your company ceased operations. If your company ceased operations before
April 1, 2023, complete Question 1-7 and return this form to the Census Bureau - you are not
required to complete the rest of this survey.

No
1-2

Did another U.S. company own more than 50% of the voting interest in your
company during 2023?
Yes ➔ Please provide the following information:
Name of parent company

EIN of owner (9 digits)

Date parent
company purchased
your company

(MM)

(DD)

(YYYY)

Is the parent company a holding company or a private equity firm [shell company,
investment company, and the like]?
Yes
No
REPORTING INSTRUCTIONS FOR U.S.-OWNED COMPANIES:
If your company was purchased by a holding company or private equity firm, you are required to
complete the rest of this survey (regardless of purchase date).
Otherwise, if your company was purchased on or after April 1, 2023, report only for the period
January 1, 2023 to the date of purchase. If your company was purchased before April 1, 2023,
then complete Question 1-7 and return this form to the Census Bureau - you are not required to
complete the rest of this survey.

No
1-3

Will the information in this survey be reported for the 2023 calendar year?
Yes
No ➔ Enter time period covered below:
(MM)

From

(YYYY)

(MM)

to

Form BRD-1

4

(YYYY)

Was your company a majority-owned subsidiary of a foreign company in 2023?
Yes ➔ Please provide the following information:
Name of parent company

REPORTING INSTRUCTIONS FOR FOREIGN-OWNED COMPANIES:
If your company is owned by a foreign parent, the reporting unit for the survey is your
U.S.-located company, including all your majority-owned subsidiaries and divisions regardless of
location. For reporting purposes, your foreign parent and any foreign affiliates your company
does not own should be treated the same as any business partner, customer, or supplier you do
not own.
If your company pays a foreign parent for R&D services, those costs should be included in your
responses in Section 2 as "costs for purchased R&D services."
If your foreign parent pays or reimburses your company for R&D services, the costs for this R&D
should be included in your responses in Section 3 as "costs funded, paid for, or reimbursed by
others."
Report your survey data using U.S. Generally Accepted Accounting Principles (U.S. GAAP) as
recognized by the Financial Accounting Standard Board (FASB). If your company follows
International Financial Reporting Standards (IFRS), we request that you estimate any adjustments
that would be required to conform to U.S. GAAP.

No
1-5

Did your company own more than 50 percent of any company operations
or subsidiaries outside the 50 United States and D.C. during 2023?
Yes ➔ Include data for these operations/subsidiaries in your survey responses
No

1-6

Did your company have discontinued operations in 2023?
Yes ➔ Include data for these operations in your survey responses
No

1-7

Who is the survey coordinator?
The survey coordinator is the person at your company responsible for gathering all requested
information, ensuring instructions are followed, and submitting the completed survey. The
survey coordinator may not be able to personally complete the entire survey and may need
to request information from other knowledgeable resources concerning your company’s R&D,
accounting, human resources, and legal matters.
Name

Telephone
Title

Area code

E-mail address

Form BRD-1

5

Number

Extension

SECTION 1

1-4

SECTION 1

1-8

What was the total number of your company’s employees worldwide for the pay
period that included March 12, 2023?
Include:
● Full- and part-time employees

Number

Exclude:
● Leased or temporary employees and consultants

1-9

How many of the employees reported in Question 1-8 were employees of
your company’s domestic operations and foreign operations?
Domestic operations employees include all employees whose payroll was reported on the
first quarter filing of IRS Form 941, Employer’s Quarterly Tax Return.
(1)
Domestic
operations

(2)
Foreign
operations

(3)
Total
employees

Employees . . . . . . . . . . . .
Total equals Question 1-8
TIP

If the number reported in Question 1-9, column 1, was fewer than 10, return this form to the
Census Bureau - you are not required to complete the rest of this survey.

Business Codes
1-10

Please describe your company’s primary business activity during 2023.

1-11

List all applicable business codes in which your company operated
worldwide in 2023.
NOTE: These codes will be used to describe both business activities and R&D activities and
may differ from industry codes used by other government surveys and reports. Tools to help
you search for appropriate business codes are available at
https://www.census.gov/programs-surveys/brds/information/brdshelp/business-codes.html.
Business code
(see pages 53-54)

Description

Form BRD-1

6

What was the amount of your company’s worldwide sales and revenues
for the year 2023?
$Bil.

Mil.

SECTION 1

1-12

Thou.

Include:
● Sales and operating revenues from discontinued operations

1-13

How much of the amount reported in Question 1-12 was attributable to or originated
from domestic operations?
Include:
● Sales and operating revenues to foreign customers,
including foreign subsidiaries
Example: U.S. Manufacturing Corporation sells parts to
customers around the world. However, because all its
operations are located inside the United States it reports 100%
of its sales in this question.

1-14

$Bil.

Mil.

Thou.

How much of the 2023 sales and operating revenue amounts was for each business
code listed or amended in Question 1-11:
(1) Worldwide sales and operating revenues reported in Question 1-12
(2) Sales and operating revenues from domestic operations reported in Question 1-13

Business code

(1)
Worldwide sales and
operating revenues
$Bil.
Mil.
Thou.

(2)
Sales and operating revenues
from domestic operations
$Bil.
Mil.
Thou.

a.
b.
c.
d.
e.
f.
g.
h.
i.

j.

Less eliminations
the sales and
revenues that are
eliminated in order
to consolidate the (
business codes. . . .

)(

)

Total . . . . . . . . . .
Total equals Question 1-12

Form BRD-1

7

Total equals Question 1-13

SECTION 2

SECTION 2

R&D Paid For by Your Company
Who should answer this section?
Persons familiar with accounting concepts and with access to financial records related to your company’s
R&D activities should complete this section.
What does this section cover?
This section requests information about your company’s R&D at multiple levels of detail: for your
worldwide consolidated enterprise, for units or parts of your company defined by geography (countries,
states, specific location), and for parts of your company defined by business code.
2-1

What was the worldwide R&D expense (both direct and indirect) for your
company in 2023?
If your company is publicly traded, this amount is equivalent
to that disclosed on SEC Form 10-K as defined in FASB ASC Topic
730, Research and Development.

$Bil.

Mil.

Thou.

If your company is foreign-owned, refer to the instructions on
page 5. Additional guidance, such as for privately owned
companies, is available online at https://www.census.gov/
programs-surveys/brds/information/brdshelp.html#q2-1
NOTE: Report your company’s R&D expense even if the amount is
not considered material for your company’s financial statements.

2-2

Does the amount reported in Question 2-1 include any of the following costs?
a. Collaborative R&D that was reimbursed by business partners,
such as through cost-sharing agreements . . . . . . . . . . . . . . . . . . . . . . . .

Yes

No

b. R&D paid for by grants (government or private foundations) . . . . . . . . .

Yes

No

c. R&D paid for by customers (customer-sponsored R&D) . . . . . . . . . . . . .
d. Technical services not an integral part of an R&D project (such as
product support provided by R&D employees) . . . . . . . . . . . . . . . . . . . .

Yes

No

Yes

No

e. Bid and proposal costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
f. Expenses for the acquisition of in-process R&D (IPR&D) or the
impairment of intangible IPR&D assets. . . . . . . . . . . . . . . . . . . . . . . . . .

Yes

No

Yes

No

g. Phase IV clinical trials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Yes

No

2-3

If you answered "Yes" to any of the costs in Question
2-2, what was the amount of these costs that were
included in your response to Question 2-1?

2-4

Subtract Question 2-3 from Question 2-1 and enter the
result here. This is the total R&D paid for by your
company in 2023.

$Bil.

Mil.

Thou.

$Bil.

Mil.

Thou.

Is the amount entered in Question 2-4:
$0 ➔

STOP

Skip to Section 3 on page 19.

Less than $1 Million ➔
Skip to Section 2 Worksheet on page 18 and then
continue with Section 3 on page 19.
STOP

$1 Million or greater ➔ Continue with Question 2-5.
Form BRD-1

8

Indirect R&D charges
How much of the amount reported in Question 2-4
was for R&D costs your company plans to recoup
through indirect charges on U.S. federal government
contracts (IR&D or independent R&D)?

$Bil.

Mil.

Thou.

SECTION 2

2-5

R&D paid for by your company
2-6

Of the amount reported in Question 2-4, what were the costs for each business
code listed or amended in Question 1-11?
If R&D costs are applicable to more than one business code allocate on a reasonable
basis. Allocation in proportion to operating revenues is acceptable unless some alternative
allocation basis is more appropriate.
$Bil.

Business code

a.

................................

b.

................................

c.

................................

d.

................................

e.

................................

f.

................................

g.

................................

h.

................................

Mil.

Thou.

i. Total (equals Question 2-4) . . . . . . . . . . . . . . . . . . . . . . . . .

2-7

Of the amount reported in Question 2-4, what costs were incurred by your
company in the following locations?
a. Domestic United States (50 states and D.C.) [Include
R&D performed by domestic operations that is paid
for by foreign subsidiaries] . . . . . . . . . . . . . . . . . . . . . . . . . .
b. All other countries (also, Puerto Rico) [Include R&D
performed by foreign subsidiaries that is paid for
by domestic operations] . . . . . . . . . . . . . . . . . . . . . . . . . . . .
c. Total (equals Question 2-4). . . . . . . . . . . . . . . . . . . . . . . . . .

Form BRD-1

9

$Bil.

Mil.

Thou.

2-8

How much of the (1) domestic, (2) foreign, and (3) worldwide R&D paid for
by your company in 2023 was for each of the following types of costs?

SECTION 2

Indirect costs that are allocated to R&D should be reported in the "All other costs" line only
if no other category is applicable. Refer to the question instructions for specific examples.

$Bil.

(1)
Domestic
Mil.

Thou.

$Bil.

(2)
Foreign
Mil.

Thou.

$Bil.

(3)
Worldwide
Mil.

Thou.

a. Salaries, wages, and fringe benefits

b. Stock-based compensation

c. Leased employees and temporary staffing, including on-site consultants, working on R&D

d. Expensed equipment (not capitalized)

e. Materials and supplies

f. Leased facilities and equipment

g. Depreciation and amortization on property, plant, equipment, and intangible assets

h. Royalties and licensing fees

(including payments made to others for the use of patents and other forms of intellectual
property used in your company’s R&D)

i. Collaborative R&D payments

j. Contract R&D

(include joint development agreements)

(include payments to your company’s foreign parent for R&D)

k. Other purchased services

Question continues on next page

Form BRD-1

10

2-8

(Continued)
$Bil.

(1)
Domestic
Mil.

$Bil.

Thou.

$Bil.

(3)
Worldwide
Mil.

Thou.

(including administrative and overhead costs clearly associated with your company’s R&D)

SECTION 2

l. All other costs

Thou.

(2)
Foreign
Mil.

m. Total

Total equals Question 2-7, line a

2-9

Total equals Question 2-7, line b

Total equals Question 2-4

Add 2-8, lines i and j for each column, and enter the result here.
This is R&D performed by others.
$Bil.

(1)
Domestic
Mil.

Thou.

$Bil.

(2)
Foreign
Mil.

Thou.

$Bil.

(3)
Worldwide
Mil.

Thou.

2-10 Subtract 2-9 from 2-8, line m, for each column and enter the result here.
This is R&D performed by your company.
$Bil.

(1)
Domestic
Mil.

Thou.

$Bil.

(2)
Foreign
Mil.

Thou.

$Bil.

(3)
Worldwide
Mil.

Thou.

2-11 Of the amount reported in Question 2-10, column 2, how much R&D was performed
in the following locations? For full list of countries in each region see Question by Question Guidance at
https://www.census.gov/programs-surveys/brds/information/brdshelp.html#q2-11.
$Bil.

Mil.

Thou.

$Bil.

Canada . . . . . . .

Finland . . . . . . .

Puerto Rico . . . .

France . . . . . . . .

Europe

$Bil.

Mil.

Germany . . . . . .

Thou.

Austria. . . . . . . .

Hungary. . . . . . .

Belgium. . . . . . .

Ireland . . . . . . . .

Czech Rep . . . . .

Italy . . . . . . . . . .

Denmark . . . . . .

Luxembourg . . .
Question continues on next page

Form BRD-1

11

Mil.

Thou.

2-15
2-11 (Continued)

SECTION 2

$Bil.

Mil.

Thou.

Netherlands . . . .

Hong Kong . . . .

Norway . . . . . . .

India . . . . . . . . .

Poland . . . . . . . .

Indonesia . . . . .

Russia . . . . . . . .

Japan . . . . . . . .

Spain. . . . . . . . .

Malaysia . . . . . .

Sweden . . . . . . .

New Zealand . . .

Switzerland . . . .

Singapore . . . . .

Turkey . . . . . . . .

South Korea . . .

United
Kingdom . . . . . .

Taiwan . . . . . . .

Other
Europe. . . . . . . .

Thailand . . . . . .

Latin America/
Other Western
Hemisphere

$Bil.

Mil.

Thou.

$Bil.

Mil.

Thou.

$Bil.

Mil.

Thou.

Other Asia/
Pacific . . . . . . . .
$Bil.

Mil.

Thou.

Middle East

Argentina . . . . . .
Israel . . . . . . . . .
Brazil . . . . . . . . .
Other
Middle East . . . .
Chile . . . . . . . . .
Africa

Mexico. . . . . . . .
Other Latin
America/OWH. . .

South Africa . . .
Other Africa . . . .

Asia and Pacific

$Bil.

Mil.

Thou.

Total (equals
Question 2-10,
column 2). . . . . .

Australia . . . . . .
China . . . . . . . . .

Form BRD-1

12

2-12 How much of the amount reported in Question 2-10, column 1, was performed
in each state (including D.C.) in 2023?
Mil.

$Bil.

Thou.

Alabama . . . . . . .

Maine . . . . . . . . .

Alaska. . . . . . . . .

Maryland . . . . . .

Arizona . . . . . . . .

Massachusetts . .

Arkansas . . . . . .

Michigan . . . . . .

California . . . . . .

Minnesota . . . . .

Colorado. . . . . . .

Mississippi . . . . .

Connecticut . . . .

Missouri . . . . . . .

Delaware . . . . . .

Montana . . . . . . .

District of
Columbia . . . . . .

Nebraska . . . . . .

Florida . . . . . . . .

Nevada . . . . . . . .

Georgia. . . . . . . .

New Hampshire

Hawaii . . . . . . . .

New Jersey. . . . .

Idaho . . . . . . . . .

New Mexico . . . .

Illinois. . . . . . . . .

New York . . . . . .

Indiana . . . . . . . .

North Carolina . .

Iowa . . . . . . . . . .

North Dakota . . .

Kansas . . . . . . . .

Ohio . . . . . . . . . .

Kentucky. . . . . . .

Oklahoma . . . . . .

Louisiana . . . . . .

Oregon . . . . . . . .
Question continues on next page

Form BRD-1

13

Mil.

Thou.

SECTION 2

$Bil.

2-12 (Continued)

SECTION 2

$Bil.

Mil.

Thou.

$Bil.

Pennsylvania. . . .

Vermont . . . . . . .

Rhode Island. . . .

Virginia . . . . . . . .

South Carolina . .

Washington . . . .

South Dakota . . .

West Virginia . . .

Tennessee . . . . .

Wisconsin . . . . .

Texas . . . . . . . . .

Wyoming . . . . . .

Utah . . . . . . . . . .

Total (equals
Question 2-10,
column 1) . . . . . .

Mil.

Thou.

2-13 At what domestic location did your company perform the largest dollar amount
of R&D in 2023?
Address 1

Address 2

City

State

2-14 How much of the amount reported in Question 2-10,
column 1, was from the location identified in
Question 2-13?

Form BRD-1

14

$Bil.

ZIP

Mil.

Thou.

2-15 At what domestic location did your company perform the second largest
dollar amount of R&D in 2023?
Address 1

City

State

2-16 How much of the amount reported in Question 2-10,
column 1, was from the location identified in
Question 2-15?

$Bil.

SECTION 2

Address 2

ZIP

Mil.

Thou.

2-17 Of the domestic R&D performed by your company reported in Question 2-10,
column 1, how much was for each business code reported in Question 2-6?
(1)
Domestic R&D performed
by your company
Business code

$Bil.

a.

................................

b.

................................

c.

................................

d.

................................

e.

................................

f.

................................

g.

................................

h.

................................

Mil.

Thou.

i. Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total equals Question 2-10, column 1

Form BRD-1

15

R&D transactions between legal entities under common ownership

SECTION 2

2-18 How much of the domestic R&D performed by your company reported in Question
2-10, column 1, was paid for by your company’s foreign subsidiaries?
Include:
● Costs for R&D performed in the United States under contract
for a foreign subsidiary
● Inter-company transactions paid to the United States from
foreign subsidiaries for transfer pricing R&D cost sharing
arrangements

$Bil.

Mil.

Thou.

Exclude:
● Payments in excess of the cost of R&D performed (profit or fees)

2-19 How much of the foreign R&D performed by your company reported in Question 2-10,
column 2, was paid for by your company’s domestic operations?
Include:
● Costs for R&D performed by your company’s foreign
subsidiaries under contract for your company’s U.S. operations
● Inter-company transactions paid from the United States to
foreign subsidiaries for transfer pricing R&D cost sharing
arrangements

$Bil.

Mil.

Thou.

Exclude:
● Payments in excess of the cost of R&D performed (profit or fees)

Projected R&D for 2025
2-20 What are your company’s projected 2025 costs for (1) domestic, (2) foreign, and
(3) worldwide R&D paid for by your company?
NOTE: These amounts are the 2025 projections for the amounts reported in
Question 2-8, line m.

$Bil.

(1)
Domestic
Mil.

Thou.

$Bil.

(2)
Foreign
Mil.

Thou.

$Bil.

2-21 How much of the amount reported in Question 2-20, column 1,
is for projected contract R&D services and projected payments
to business partners for collaborative R&D?
$Bil.

NOTE: This amount is the 2025 projection for the amount
reported in Question 2-9, column 1.

Form BRD-1

16

(3)
Worldwide
Mil.

Thou.

Domestic
Mil.

Thou.

2-22 Who was primarily responsible for completing this section?
Same person mentioned in Question 1-7

Name

Telephone
Title

Area code

Form BRD-1

17

Number

Extension

SECTION 2

Another person ➔ Please provide the following information:

SECTION 2 WORKSHEET
Complete if amount reported in Question 2-4 is less than $1 Million

SECTION 2

1

Of the total R&D paid for by your company reported in Question 2-4, what costs
were incurred in the following locations?
a. Domestic United States (50 states and D.C.) [Include R&D
performed by domestic operations that is paid for by foreign
subsidiaries] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$Mil.

Thou.

b. All other countries (also, Puerto Rico) [Include R&D performed
by foreign subsidiaries that is paid for by domestic operations] . . . . .
c. Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2

How much of the amount reported in Question 1, line a, was for each of the
following types of costs?
$Mil.

Thou.

$Mil.

Thou.

a. Salaries, wages, and fringe benefits. . . . . . . . . . . . . . . . . . . . . . . . . . .
b. Depreciation and amortization on property, plant, equipment,
and intangible assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
c. Collaborative R&D payments
d. Contract R&D

(include joint development agreements)

......

(include payments to your company’s foreign parent for R&D)

e. All other costs

(including administrative and overhead costs
clearly associated with your company’s R&D) . . . . . . . . .

....

..............

f. Total (equals Question 1, line a) . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

3

Add Question 2, lines a, b, and e, and enter the result here.
This is the domestic R&D paid for and performed by your
company in 2023.

4

Of the domestic R&D paid for and performed by your company reported in
Question 3, how much was for the following categories?
a. Basic research activities aimed at acquiring new knowledge
or understanding without specific immediate commercial
applications or uses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
b. Applied research activities aimed at solving a specific
problem or meeting a specific commercial objective . . . . . . . . . . . . . .
c. Development systematic work, drawing on research and
practical experience and resulting in additional knowledge,
which is directed to producing new products or processes
or to improving existing products or processes . . . . . . . . . . . . . . . . . .
d. Total (equals Question 3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Form BRD-1

18

$Mil.

Thou.

SECTION 3
Costs Paid For by Others
Who should answer this section?
Persons familiar with accounting concepts and with access to financial records related to your
company’s activities paid for by others should complete this section.

3-1

What were your company’s worldwide costs (both direct and indirect) in 2023 for
the following that were funded, paid for, or reimbursed by others not owned by
your company?
Exclude:
● Costs that were paid for by your company, such as those reported in Question 2-4
● Payments in excess of the actual cost of the work performed (such as profit or fees)
$Bil.

a. R&D reimbursed by your company’s foreign
parent (if you are owned by a foreign parent) . . . . . . . . . . . .
b. Collaborative R&D reimbursed by business partners,
such as through cost-sharing agreements . . . . . . . . . . . . . . .
c. R&D paid for by grants (government or private
foundations). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
d. Defense R&D goods or services provided as a prime
or as a sub, to the government and/or government
contractors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Exclude:
● Costs for projects that have achieved technical feasibility, such as
low-rate initial production. Additional guidance is available online
at https://www.census.gov/programs-surveys/brds/information.html

e. Medical clinical trial Phase I-III services provided to others
not owned by your company (include pass-through costs) . .
f. Medical R&D services, other than clinical trials, provided
to others not owned by your company . . . . . . . . . . . . . . . . .
g. Nondefense custom software development and/or
computer systems designed for others not owned by
your company . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Exclude:
● Software development that does not depend on a scientific or
technological advance, such as adding functionality to existing
application programs, debugging systems, and adapting
existing software

h. Prototype development, production, and testing for
customer’s products prior to their introduction to the
market (excluding defense-related prototyping reported
in line d) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
i. All other R&D services provided to the Federal Government
or to others not owned by your company . . . . . . . . . . . . . . .
j. Total. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Form BRD-1

19

Mil.

Thou.

SECTION 3

What does this section cover?
Topics include customer-sponsored work and activities funded through grants, contracts, and/or
reimbursements. Costs for these activities are requested at multiple levels of detail: for your worldwide
consolidated enterprise, for units or parts of your company defined by geography (countries, states),
and for parts of your company defined by business code.

3-1

(Continued)
The amount entered in Question 3-1, line j is the total R&D paid for by others in 2023.
Is this amount:
$0 ➔
If Question 2-4 was also $0, then you have completed this survey,
otherwise skip to Section 4 on page 33.
STOP

Less than $1 Million ➔
Skip to Section 3 Worksheet on page 31 and then
continue with Section 4 on page 33.
STOP

$1 Million or greater ➔ Continue with Question 3-2.

SECTION 3

R&D paid for by others
3-2

Of the amount reported in Question 3-1, line j, what costs were incurred
by your company in the following locations?
$Bil.
Mil.

Thou.

a. Domestic United States (50 states and D.C.) . . . . . . . . . . . . .
b. All other countries (also, Puerto Rico) . . . . . . . . . . . . . . . . . .
c. Total (equals Question 3-1, line j) . . . . . . . . . . . . . . . . . . . . .
3-3

How much of the (1) domestic, (2) foreign, and (3) worldwide R&D paid for by
others in 2023 was for each of the following types of costs?
Indirect costs that are allocated to R&D should be reported in the "All other costs" line only
if no other category is applicable. Refer to the question instructions for specific examples.

$Bil.

(1)
Domestic
Mil.

Thou.

$Bil.

(2)
Foreign
Mil.

Thou.

$Bil.

(3)
Worldwide
Mil.

a. Salaries, wages, and fringe benefits

b. Stock-based compensation

c. Leased employees and temporary staffing, including on-site consultants, working on R&D

d. Expensed equipment (not capitalized)

e. Materials and supplies

Question continues on next page

Form BRD-1

20

Thou.

3-3

(Continued)
$Bil.

(1)
Domestic
Mil.

Thou.

$Bil.

(2)
Foreign
Mil.

Thou.

$Bil.

(3)
Worldwide
Mil.

Thou.

f. Leased facilities and equipment

g. Depreciation and amortization on property, plant, equipment, and intangible assets

h. Royalties and licensing fees

i. Collaborative R&D payments

SECTION 3

(including payments made to others for the use of patents and other forms of intellectual
property used in your company’s R&D)

(include joint development agreements)

j. Contract R&D (include payments to your company’s foreign parent for R&D)

k. Other purchased services

l. All other costs

(including administrative and overhead costs clearly associated with your company’s R&D)

m. Total

Total equals Question 3-2, line a

3-4

Total equals Question 3-1, line j

Add 3-3, lines i and j for each column, and enter the result here.
This is R&D performed by others (e.g., subcontracted/passed-through R&D costs).
$Bil.

3-5

Total equals Question 3-2, line b

(1)
Domestic
Mil.

Thou.

$Bil.

(2)
Foreign
Mil.

Thou.

$Bil.

(3)
Worldwide
Mil.

Thou.

Subtract 3-4 from 3-3, line m, for each column and enter the result here.
This is R&D performed by your company that was paid for by others.
$Bil.

(1)
Domestic
Mil.

Thou.

$Bil.

(2)
Foreign
Mil.

Form BRD-1

21

Thou.

$Bil.

(3)
Worldwide
Mil.

Thou.

3-6

Of the amount reported in Question 3-5, column 2, how much R&D was performed
in the following locations? For full list of countries in each region see Question by Question Guidance at
https://www.census.gov/programs-surveys/brds/information/brdshelp.html#q3-6.
$Bil.

Mil.

Thou.

Canada . . . . . . .

Switzerland . . . .

Puerto Rico . . . .

Turkey . . . . . . . .

Europe

$Bil.

Mil.

Thou.

Mil.

Thou.

$Bil.

Mil.

Thou.

$Bil.

Mil.

Thou.

United
Kingdom . . . . . .

Austria . . . . . . .

SECTION 3

$Bil.

Other
Europe. . . . . . . .

Belgium. . . . . . .

Latin America/
Other Western
Hemisphere

Czech Rep . . . . .
Argentina. . . . . .
Denmark . . . . . .
Brazil . . . . . . . . .
Finland . . . . . . .
Chile . . . . . . . . .
France . . . . . . . .
Mexico. . . . . . . .
Germany . . . . . .

Other Latin
America/OWH . .

Hungary . . . . . . .

Asia and Pacific

Ireland . . . . . . . .

Australia . . . . . .

Italy . . . . . . . . . .

China. . . . . . . . .

Luxembourg . . .

Hong Kong . . . .

Netherlands . . . .

India . . . . . . . . .

Norway . . . . . . .

Indonesia . . . . .

Poland . . . . . . . .

Japan . . . . . . . .

Russia . . . . . . . .

Malaysia . . . . . .

Spain. . . . . . . . .

New Zealand . . .

Sweden . . . . . . .

Singapore . . . . .
Question continues on next page

Form BRD-1

22

3-6

(Continued)
$Bil.

Mil.

Thou.

Africa

South Korea . . .

South Africa. . . .

Taiwan . . . . . . .

Other Africa . . . .

Thailand . . . . . .

Total (equals
Question 3-5,
column 2). . . . . .

$Bil.

Mil.

Thou.

Other Asia/
Pacific . . . . . . . .
$Bil.

Mil.

Thou.

SECTION 3

Middle East

Israel . . . . . . . . .
Other
Middle East . . . .

3-7

How much of the domestic R&D performed by your company that was paid for by
others reported in Question 3-5, column 1, was for each business code listed or
amended in Question 1-11?
If R&D is applicable to more than one business code allocate on a reasonable basis.
Allocation in proportion to operating revenues is acceptable unless some alternative allocation
basis is more appropriate.
Business code

$Bil.

a.

................................

b.

................................

c.

................................

d.

................................

e.

................................

f.

................................

g.

................................

h.

................................

i. Total (equals Question 3-5, column 1) . . . . . . . . . . . . . . . . .

Form BRD-1

23

Mil.

Thou.

3-8

How much of the amount reported in Question 3-5, column 1, was paid for by each
of the following?
If your company is a subcontractor or subgrantee, report the original source of funds.
Example: Company Sub Inc. performs custom software development for a large defense company as
a subcontractor on a contract with the U.S. Dept. of Defense. Even though Sub Inc. is working directly
for the defense company, it reports the cost of this development in line d because the Dept. of Defense
was the original source of funds.
$Bil.

Mil.

Thou.

$Bil.

Mil.

Thou.

$Bil.

Mil.

Thou.

a. Other companies located inside the United States. . . . . . . . .

SECTION 3

b. Your company’s foreign parent (if you are owned by a
foreign parent). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
c. Other companies located outside the United States . . . . . . .
d. U.S. federal government agencies or laboratories . . . . . . . . .
e. U.S. state and local government agencies or laboratories . . .
f. Foreign government agencies or laboratories . . . . . . . . . . . .
g. Universities, colleges, and academic researchers (including
principal investigators) located inside the United States . . . .
h. Universities and colleges located outside the United States. .
i. All other organizations inside the United States . . . . . . . . . .
j. All other organizations outside the United States . . . . . . . . .
k. Total (equals Question 3-5, column 1). . . . . . . . . . . . . . . . . .

3-9

Add Question 3-8, lines a, b, and c, and enter the
result here. This is the domestic R&D performed by
your company that was paid for by other companies.

3-10 Subtract Question 3-8, line d, from Question 3-8, line k,
and enter the result here. This is the domestic R&D
performed by your company that was paid for by
nonfederal sources.

Form BRD-1

24

3-11 How much of the following three amounts was performed in each state
(including D.C.):
(1) Domestic R&D paid for by the U.S. federal government reported in Question 3-8,
line d
(2) Domestic R&D paid for by nonfederal sources reported in Question 3-10
(3) Total domestic R&D performed by your company that was paid for by others
reported in Question 3-5, column 1

$Bil.

(1)
Federal
Mil.

Thou.

$Bil.

(2)
Nonfederal
Mil.

Thou.

$Bil.

(3)
Total
Mil.

Thou.

Alabama

SECTION 3

Alaska

Arizona

Arkansas

California

Colorado

Connecticut

Delaware

District of Columbia

Florida

Georgia

Hawaii

Question continues on next page
Form BRD-1

25

3-11 (Continued)
$Bil.

(1)
Federal
Mil.

Thou.

$Bil.

(2)
Nonfederal
Mil.

Thou.

Idaho

Illinois

SECTION 3

Indiana

Iowa

Kansas

Kentucky

Louisiana

Maine

Maryland

Massachusetts

Michigan

Minnesota

Mississippi

Question continues on next page

Form BRD-1

26

$Bil.

(3)
Total
Mil.

Thou.

3-11 (Continued)
$Bil.

(1)
Federal
Mil.

Thou.

$Bil.

(2)
Nonfederal
Mil.

Thou.

$Bil.

(3)
Total
Mil.

Thou.

Missouri

Montana

SECTION 3

Nebraska

Nevada

New Hampshire

New Jersey

New Mexico

New York

North Carolina

North Dakota

Ohio

Oklahoma

Oregon

Question continues on next page

Form BRD-1

27

3-11 (Continued)
$Bil.

(1)
Federal
Mil.

Thou.

$Bil.

(2)
Nonfederal
Mil.

Thou.

Pennsylvania

Rhode Island

SECTION 3

South Carolina

South Dakota

Tennessee

Texas

Utah

Vermont

Virginia

Washington

West Virginia

Wisconsin

Wyoming

Question continues on next page

Form BRD-1

28

$Bil.

(3)
Total
Mil.

Thou.

3-11 (Continued)
$Bil.

(1)
Federal
Mil.

Thou.

$Bil.

(2)
Nonfederal
Mil.

Thou.

$Bil.

(3)
Total
Mil.

Thou.

Total

Total equals Question 3-8, line d

Total equals Question 3-10

Total equals Question 3-5, column 1

3-12 At what domestic location did your company perform the largest dollar amount
of R&D that was paid for by others in 2023?

SECTION 3

Address 1

Address 2

City

State

3-13 How much of the amount reported in Question 3-5,
column 1, was from the location identified in
Question 3-12?

$Bil.

ZIP

Mil.

Thou.

3-14 At what domestic location did your company perform the second largest
dollar amount of R&D that was paid for by others in 2023?
Address 1

Address 2

City

State

3-15 How much of the amount reported in Question 3-5,
column 1, was from the location identified in
Question 3-14?

Form BRD-1

29

$Bil.

ZIP

Mil.

Thou.

R&D performed by others
3-16 Of the domestic R&D performed by others reported
in Question 3-4, column 1, how much was paid for by
U.S. federal government agencies or laboratories?

$Bil.

Mil.

Thou.

$Bil.

Mil.

Thou.

$Bil.

Mil.

Thou.

$Bil.

Mil.

Thou.

Projected R&D paid for by others in 2025

SECTION 3

3-17 What are your company’s projected 2025 costs for R&D
that will be paid for by others?
NOTE: This amount is the 2025 projection for what is
reported in Question 3-1, line j.

3-18 How much of the projected costs in 2025 for R&D that
will be paid for by others reported in Question 3-17
will be performed by your company in the United
States?
NOTE: This amount is the 2025 projection for what is
reported in Question 3-5, column 1.

3-19 How much of the projected costs in 2025 for domestic
R&D performed by your company reported in Question
3-18 will be paid for by the U.S. federal government?
NOTE: This amount is the 2025 projection for what is
reported in Question 3-8, line d.

3-20 Who was primarily responsible for completing this section?
Same person mentioned in Question 1-7
Another person ➔ Please provide the following information:
Name

Telephone
Title

Area code

Form BRD-1

30

Number

Extension

SECTION 3 WORKSHEET
Complete if amount reported in Question 3-1, line j is less than $1 Million
1

Of the total R&D paid for by others reported in Question 3-1, line j, what costs
were incurred in the following locations?
$Mil.

Thou.

a. Domestic United States (50 states and D.C.) . . . . . . . . . . . . . . . . . . . .

SECTION 3

b. All other countries (also, Puerto Rico) . . . . . . . . . . . . . . . . . . . . . . . . .
c. Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2

How much of the amount reported in Question 1, line a, was for each of the
following types of costs?
$Mil.

Thou.

$Mil.

Thou.

a. Salaries, wages, and fringe benefits . . . . . . . . . . . . . . . . . . . . . . . . . .
b. Depreciation and amortization on property, plant,
equipment, and intangible assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
c. Collaborative R&D payments
d. Contract R&D

(include joint development agreements)

......

(include payments to your company’s foreign parent for R&D)

e. All other costs

(including administrative and overhead costs
clearly associated with your company’s R&D) . . . . . . . . .

....

..............

f. Total (equals Question 1, line a) . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

3

Add Question 2, lines a, b, and e, and enter the result here.
This is the domestic R&D performed by your company that
was paid for by others in 2023.

Form BRD-1

31

4

How much of the amount reported in Question 3, was paid for by each of the
following?
If your company is a subcontractor or subgrantee, report the original source of funds.
Example: Company Sub Inc. performs custom software development for a large defense company as
a subcontractor on a contract with the U.S. Dept. of Defense. Even though Sub Inc. is working directly
for the defense company, it reports the cost of this development in line d because the Dept. of Defense
was the original source of funds.
$Mil.

Thou.

a. Other companies located inside the United States . . . . . . . . . . . . . . .

SECTION 3

b. Your company’s foreign parent (if you are owned by a
foreign parent) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
c. Other companies located outside the United States . . . . . . . . . . . . . .
d. U.S. federal government agencies or laboratories . . . . . . . . . . . . . . . .
e. U.S. state and local government agencies or laboratories . . . . . . . . .
f. Foreign government agencies or laboratories . . . . . . . . . . . . . . . . . . .
g. Universities, colleges, and academic researchers (including
principal investigators) located inside the United States . . . . . . . . . . .
h. Universities and colleges located outside the United States . . . . . . . .
i. All other organizations inside the United States . . . . . . . . . . . . . . . . .
j. All other organizations outside the United States . . . . . . . . . . . . . . . .
k. Total (equals Question 3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

5

Of the domestic R&D performed by your company that was paid for by others
reported in Question 3, how much was for the following categories?
a. Basic research activities aimed at acquiring new knowledge
or understanding without specific immediate commercial
applications or uses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
b. Applied research activities aimed at solving a specific
problem or meeting a specific commercial objective . . . . . . . . . . . . .
c. Development systematic work, drawing on research and
practical experience and resulting in additional knowledge,
which is directed to producing new products or processes
or to improving existing products or processes . . . . . . . . . . . . . . . . .
d. Total (equals Question 3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Form BRD-1

32

$Mil.

Thou.

SECTION 4
Assets
Who should answer this section?
Persons familiar with your company’s accounting for capital expenditures and assets and with access
to records related to those should complete this section.
What does this section cover?
The purpose of this section is to measure the stock of capital, both tangible and intangible, your
company owns and uses in the course of its business and the investments it has made in these
assets during 2023. Many of the questions in this section will tie directly to your company’s financial
statements.
4-1

What was the net worldwide value of the following assets owned or leased
by your company at the end of 2023, according to your balance sheet?
Include:
● Assets classified as discontinued operations

$Bil.

Mil.

Thou.

$Bil.

Mil.

Thou.

a. Property, plant, and equipment . . . . . . . . . . . . . . . . . . . . . . .

SECTION 4

b. Goodwill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
c. Identifiable intangible assets . . . . . . . . . . . . . . . . . . . . . . . . .
d. Total. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4-2

What were your company’s worldwide expenditures for the
following capitalized assets in 2023?
Include:
● Estimated cost of new structures and equipment acquired as the
lessee under lease arrangements entered into during 2023.
● Capitalized internal software development costs.
Exclude:
● Assets acquired through mergers and acquisitions reported in
Question 4-1.
● Investment in operating leases (expenditures for fixed assets
leased to others).

a. Property, plant, and equipment . . . . . . . . . . . . . . . . . . . . . . .
b. Identifiable intangible assets . . . . . . . . . . . . . . . . . . . . . . . . .
c. Total. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Form BRD-1

33

4-3

How much of the expenditures for capitalized assets in Question 4-2 were for
assets that were deployed in the following locations?

$Bil.

(1)
Domestic
Mil.

Thou.

$Bil.

(2)
Foreign
Mil.

Thou.

$Bil.

(3)
Worldwide
Mil.

Thou.

a. Property, plant, and equipment

b. Identifiable intangible assets

c. Total

SECTION 4

4-4

Of the amounts reported in Question 4-3, Column 1 (Domestic), how much was for
R&D operations?
Include:
● Expenditures for business operations that research and develop
new and improved products for sale by your company.
● Expenditures for business operations that research and develop
new and improved processes and software for use by your
company.
● Expenditures for business operations that conduct R&D that is
paid for by customers, business partners, or other third parties.
Companies should allocate capital expenditures that benefit both
R&D operations and other company operations on a reasonable
basis.
$Bil.

a. Property, plant, and equipment . . . . . . . . . . . . . . . . . . . . . . .
b. Identifiable intangible assets . . . . . . . . . . . . . . . . . . . . . . . . .
c. Total. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Form BRD-1

34

Mil.

Thou.

4-5

How much of the amount reported in Question 4-4, line c, was for the following?
$Bil.

Mil.

Thou.

a. Land acquisition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
b. Buildings and land improvement. . . . . . . . . . . . . . . . . . . . . .
c. Machinery and equipment. . . . . . . . . . . . . . . . . . . . . . . . . . .
d. Capitalized software . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
e. Other intellectual property. . . . . . . . . . . . . . . . . . . . . . . . . . .
f. All other capital expenditures for R&D operations. . . . . . . . .

4-6

SECTION 4

g. Total (equals Question 4-4, line c). . . . . . . . . . . . . . . . . . . . .

Who was primarily responsible for completing this section?
Same person mentioned in Question 1-7
Another person ➔ Please provide the following information:
Name

Telephone
Title

Area code

Form BRD-1

35

Number

Extension

SECTION 5
Management and Strategy of R&D
Who should answer this section?
Persons familiar with the technical, managerial, and strategic aspects of your company’s R&D should
complete this section.
What does this section cover?
This section requests information about the characteristics of the R&D reported in Sections 2 and 3.
This section requests information about your company’s worldwide consolidated R&D and the R&D
your company performs in the domestic United States.
TIP

If the amount reported in Question 2-4 was less than $1 Million, skip to Question 5-11 on page 38.

5-1

What percentage of the total R&D paid for by your company reported in Question 2-4
was directed toward business areas or product lines that are new to your company?
Example: Company A manufactures laptop computers. In 2023, Company A’s
management decided to attempt to enter the cellular phone market and used a portion
of the company’s R&D budget to develop cellular phones. Because this was a new line
of business in 2023, Company A reports this R&D in this question.

%

5-2

Copy the amount from Question 2-10, column 1.
This is the domestic R&D paid for and performed
by your company.

5-3

How much of the amount reported in Question 5-2
was for the following categories?

$Bil.

Mil.

Thou.

$Bil.

Mil.

Thou.

$Bil.

Mil.

Thou.

a. Research planned, systematic pursuit of new
knowledge or understanding . . . . . . . . . . . . . . . . . . . . . . . . .
b. Development systematic work, drawing on research
and practical experience and resulting in additional
knowledge, which is directed to producing new
products or processes or to improving existing
products or processes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
c. Total (equals Question 5-2) . . . . . . . . . . . . . . . . . . . . . . . . . .

5-4

If you reported any research in Question 5-3, line a, how
much of that research was for the following categories?
a. Applied research activities aimed at solving a specific
problem or meeting a specific commercial objective . . . . . . .
b. Basic research activities aimed at acquiring new
knowledge or understanding without specific immediate
commercial applications or uses . . . . . . . . . . . . . . . . . . . . . .
c. Total (equals Question 5-3, line a) . . . . . . . . . . . . . . . . . . . .

Form BRD-1

36

SECTION 5

Characteristics of domestic R&D paid for and performed by your company

Technology focus of domestic R&D paid for and performed by your company
NOTE: You may report the same R&D in multiple areas for Questions 5-5 to 5-8.
5-5

What percentage of the amount reported in Question 5-2 was for
software products or software embedded in other projects or products?

5-6

What percentage of the amount reported in Question 5-2 was for
biotechnology? For list-based definition see Question by Question Guidance at

%

https://www.census.gov/programs-surveys/brds/information/brdshelp.html#q5-6

Biotechnology The application of science and technology to living organisms,
as well as parts, products and models thereof, to alter living or non-living materials
for the production of knowledge, goods and services.

5-7

%

What percentage of the amount reported in Question 5-2 was for
nanotechnology? For list-based definition see Question by Question Guidance at
https://www.census.gov/programs-surveys/brds/information/brdshelp.html#q5-7

Nanotechnology The application of science and technology to organisms,
organic and inorganic materials, as well as parts, products, and models thereof,
at the nanometer-scale (but not exclusively below 1000 nanometers).

5-8

%

What percentage of the amount reported in Question 5-2 was for
artificial intelligence (AI)? For a detailed definition see Question by Question
Guidance at https://www.census.gov/programs-surveys/brds/information/brdshelp.html#q5-8

SECTION 5

Artificial Intelligence (AI) A branch of computer science and engineering devoted
to making machines intelligent. Intelligence is that quality that enables an entity to
perceive, analyze, determine response, and act appropriately in its environment.

%

Characteristics of foreign R&D paid for and performed by your company
5-9

Copy the amount from Question 2-10, column 2.
This is the foreign R&D paid for and performed
by your company.

5-10 How much of the foreign R&D paid for and performed
by your company reported in Question 5-9 was for
the following categories?
a. Research planned, systematic pursuit of new
knowledge or understanding . . . . . . . . . . . . . . . . . . . . . . . . .
b. Development systematic work, drawing on research
and practical experience and resulting in additional
knowledge, which is directed to producing new
products or processes or to improving existing
products or processes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
c. Total (equals Question 5-9) . . . . . . . . . . . . . . . . . . . . . . . . .

Form BRD-1

37

$Bil.

Mil.

Thou.

$Bil.

Mil.

Thou.

Domestic R&D performed by your company that was paid for by others
TIP

If the amount reported in Question 3-1, line j was less than $1 Million, skip to Section 6 on page 41.

5-11 Copy the amount from Question 3-5, column 1. This
is the domestic R&D performed by your company that
was paid for by others.

5-12 How much of the amount reported in Question 5-11
was for the following categories?

$Bil.

Mil.

Thou.

$Bil.

Mil.

Thou.

$Bil.

Mil.

Thou.

a. Research planned, systematic pursuit of new
knowledge or understanding . . . . . . . . . . . . . . . . . . . . . . . . .
b. Development systematic work, drawing on research and
practical experience and resulting in additional knowledge,
which is directed to producing new products or processes
or to improving existing products or processes . . . . . . . . . . .
c. Total (equals Question 5-11) . . . . . . . . . . . . . . . . . . . . . . . . .

5-13 If you reported any research in Question 5-12, line a, how
much of that research was for the following categories?

b. Basic research activities aimed at acquiring new
knowledge or understanding without specific immediate
commercial applications or uses . . . . . . . . . . . . . . . . . . . . . .
c. Total (equals Question 5-12, line a). . . . . . . . . . . . . . . . . . . .

Form BRD-1

38

SECTION 5

a. Applied research activities aimed at solving a specific
problem or meeting a specific commercial objective . . . . . . .

Technology focus of domestic R&D performed by your company
that was paid for by others
NOTE: You may report the same R&D in multiple areas for Questions 5-14 to 5-17.
5-14 What percentage of the amount reported in Question 5-11 was for
software products or software embedded in other projects or
products?

%

5-15 What percentage of the amount reported in Question 5-11 was for
biotechnology? For list-based definition see Question by Question Guidance at
https://www.census.gov/programs-surveys/brds/information/brdshelp.html#q5-15

Biotechnology The application of science and technology to living organisms,
as well as parts, products and models thereof, to alter living or non-living materials
for the production of knowledge, goods and services.

%

5-16 What percentage of the amount reported in Question 5-11 was for
nanotechnology? For list-based definition see Question by Question Guidance at
https://www.census.gov/programs-surveys/brds/information/brdshelp.html#q5-16

Nanotechnology The application of science and technology to organisms,
organic and inorganic materials, as well as parts, products, and models thereof,
at the nanometer-scale (but not exclusively below 1000 nanometers).

%

5-17 What percentage of the amount reported in Question 5-11 was for
artificial intelligence (AI)? For a detailed definition see Question by Question

SECTION 5

Guidance at https://www.census.gov/programs-surveys/brds/information/brdshelp.html#q5-17

Artificial Intelligence (AI) A branch of computer science and engineering devoted
to making machines intelligent. Intelligence is that quality that enables an entity to
perceive, analyze, determine response, and act appropriately in its environment.

%

Domestic R&D performed by your company that was paid for by the
U.S. federal government
5-18 Copy the amount from Question 3-8, line d. This is
the domestic R&D performed by your company that
was paid for by the U.S. federal government.
5-19 How much of the amount reported in Question 5-18
was for the following categories?
a. Research planned, systematic pursuit of new
knowledge or understanding . . . . . . . . . . . . . . . . . . . . . . . . .
b. Development systematic work, drawing on research and
practical experience and resulting in additional knowledge,
which is directed to producing new products or processes
or to improving existing products or processes . . . . . . . . . . .
c. Total (equals Question 5-18) . . . . . . . . . . . . . . . . . . . . . . . . .

Form BRD-1

39

$Bil.

Mil.

Thou.

$Bil.

Mil.

Thou.

5-20 If you reported any research in Question 5-19, line a,
how much was for the following categories?

$Bil.

Mil.

Thou.

a. Applied research activities aimed at solving a specific
problem or meeting a specific commercial objective . . . . . . .
b. Basic research activities aimed at acquiring new
knowledge or understanding without specific immediate
commercial applications or uses . . . . . . . . . . . . . . . . . . . . . .
c. Total (equals Question 5-19, line a) . . . . . . . . . . . . . . . . . . . .
5-21 What percentage of the amount reported in Question 5-18 was
for software products or software embedded in other projects
or products?

%

Characteristics of foreign R&D performed by your company that was paid
for by others
5-22 Copy the amount from Question 3-5, column 2. This is
the foreign R&D performed by your company and paid
for by others.
5-23 How much of the amount reported in Question 5-22
was for the following categories?

$Bil.

Mil.

Thou.

$Bil.

Mil.

Thou.

SECTION 5

a. Research planned, systematic pursuit of new
knowledge or understanding . . . . . . . . . . . . . . . . . . . . . . . . .
b. Development systematic work, drawing on research and
practical experience and resulting in additional knowledge,
which is directed to producing new products or processes
or to improving existing products or processes . . . . . . . . . . .
c. Total (equals Question 5-22) . . . . . . . . . . . . . . . . . . . . . . . . .
5-24 Who was primarily responsible for completing this section?
Same person mentioned in Question 1-7
Another person ➔ Please provide the following information:
Name

Telephone
Title

Area code

Form BRD-1

40

Number

Extension

SECTION 6
Human Resources
Who should answer this section?
Persons familiar with human resources concepts and with access to records related to your company’s
employees should complete this section.
What does this section cover?
This section requests information about your company’s employees, focusing on those who worked on
R&D activities either full-time or part-time. Include employment data for operations or subsidiaries for
which your company owned more than 50 percent.
6-1

How many employees reported in Question 1-9 were R&D employees and how
many were all other employees?
Include: Full-and part-time employees
Exclude: Leased or temporary employees and consultants
R&D employees include: All employees who work on R&D or who provide direct support to R&D, such
as researchers, R&D managers, technicians, clerical staff, and others assigned to R&D groups.
R&D employees exclude: Employees who provide only indirect support to R&D, such as corporate
personnel, security guards, and cafeteria workers.
(1)
Domestic
operations

(2)
Foreign
operations

(3)
Total
employees

a. R&D employees . . . . . .
b. All other employees . . .
c. Total employees . . . . .

6-2

How many of the employees reported in Question 6-1, column 1, were employed in
each state (including D.C.)?
(1)
R&D employees

(2)
Total employees

(1)
R&D employees

Alabama

California

Alaska

Colorado

Arizona

Connecticut

Arkansas

Delaware

Question continues on next page
Form BRD-1

41

(2)
Total employees

SECTION 6

Total line equals Question 1-9

SECTION 6

6-2

(Continued)
(1)
R&D employees

(2)
Total employees

(1)
R&D employees

District of Columbia

Michigan

Florida

Minnesota

Georgia

Mississippi

Hawaii

Missouri

Idaho

Montana

Illinois

Nebraska

Indiana

Nevada

Iowa

New Hampshire

Kansas

New Jersey

Kentucky

New Mexico

Louisiana

New York

Maine

North Carolina

Maryland

North Dakota

Massachusetts

Ohio

Question continues on next page
Form BRD-1

42

(2)
Total employees

(Continued)
(1)
R&D employees

6-3

(2)
Total employees

(1)
R&D employees

Oklahoma

Utah

Oregon

Vermont

Pennsylvania

Virginia

Rhode Island

Washington

South Carolina

West Virginia

South Dakota

Wisconsin

Tennessee

Wyoming

Texas

Total

(2)
Total employees

How many of the employees reported in Question 6-1, column 2, were employed in
each location (including Puerto Rico)?
(1)
R&D employees

(2)
Total employees

(1)
R&D employees

Canada

Czech Rep

Puerto Rico

Denmark

Finland

Europe

Austria
France
Belgium

Question continues on next page
Form BRD-1

43

(2)
Total employees

SECTION 6

6-2

6-3

(Continued)
(1)
R&D employees

(2)
Total employees

(1)
R&D employees

Germany

United Kingdom

Hungary

Other Europe

Ireland

Latin America/Other Western Hemisphere

Argentina
Italy
Brazil
Luxembourg
Chile
Netherlands
Mexico
Norway
Other Latin America/OWH
Poland
Asia and Pacific

SECTION 6

(2)
Total employees

Russia

Australia

Spain

China

Sweden

Hong Kong

Switzerland

India

Turkey

Indonesia

Question continues on next page
Form BRD-1

44

6-3

(Continued)
(1)
R&D employees

(2)
Total employees

(1)
R&D employees

Japan

(2)
Total employees

Middle East

Israel
Malaysia
Other Middle East
New Zealand
Africa

Singapore

South Africa

South Korea

Other Africa

Taiwan

Total

Thailand

R&D employees
6-4

How many of the R&D employees reported in Question 6-1, line a, were female
employees and male employees?
(1)
Domestic Operations

(2)
Foreign Operations

(3)
Total R&D employees

a. Female R&D employees
b. Male R&D employees . .
c. Total R&D employees
Total line equals Question 6-1, line a

Form BRD-1

45

SECTION 6

Other Asia/Pacific

6-5

How many of the R&D employees reported in Question 6-1, line a, worked in the
occupations listed below?
a. Researchers (including
R&D scientists,
engineers, and their
managers) . . . . . . . . . . .

(1)
Domestic Operations

(2)
Foreign Operations

(3)
Total R&D employees

b. R&D technicians and
equivalent staff . . . . . . .
c. R&D support staff
(clerical and other) . . . .
d. Total R&D employees
Total
Question continues
on line
nextequals
page Question 6-1, line a

6-6

How many of the researchers reported in Question 6-5, line a, had the following
level of education?
(1)
Domestic Operations

(2)
Foreign Operations

(3)
Total

PhD (excluding MD,
JD, and EdD) . . . . . . . . . . .

Domestic full-time equivalents (FTEs)
6-7

Of the domestic R&D employees reported in Question 6-1, line a, column 1, what
was the number of full-time equivalents (FTEs) for R&D activity for full-time R&D
employees, other full-time employees not working solely on R&D, and part-time
employees?
Number

a. FTEs for full-time R&D employees

SECTION 6

Count the number of full-time employees who work only on R&D. . . . .
Example:
50 full-time R&D employees worked only on R&D = 50 FTEs

b. FTEs for other full-time employees not working solely on R&D
Use the share of the time they work on R&D to calculate the
number of FTEs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
........
Example:
60 full-time employees averaged one-fourth of their time on R&D = 15 FTEs
c. FTEs for part-time employees working on R&D
Use the share of a full-time week (such as 40 hours) that they work
on R&D to calculate the FTEs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
........
Example:
20 part-time employees averaged 20 hours a week on R&D activities = 10 FTEs

d. Total FTEs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total FTEs should not exceed Question 6-1, line a, column 1.
Form BRD-1

46

6-8

Of the domestic researchers reported in Question 6-5, line a, column 1, what was
the number of full-time equivalents (FTEs) for R&D activity for full-time R&D
employees, other full-time employees not working solely on R&D, and part-time
employees?
Number

a. FTEs for full-time researchers
Count the number of full-time employees who work only on R&D. . . . .
Example:
50 full-time R&D scientists worked only on R&D = 50 FTEs

b. FTEs for other full-time researchers not working solely on R&D
Use the share of the time they work on R&D to calculate the
number of FTEs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
........
Example:
60 full-time managers averaged one-fourth of their time on R&D = 15 FTEs
c. FTEs for part-time researchers working on R&D
Use the share of a full-time week (such as 40 hours) that they work
on R&D to calculate the FTEs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
........
Example:
20 part-time employees averaged 20 hours a week on R&D activities = 10 FTEs

d. Total FTEs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total FTEs should not exceed Question 6-5, line a, column 1.
6-9

How many of the domestic researchers reported in Question 6-5, line a, column 1,
were non-U.S. citizens employed in the United States under a temporary visa, such
as H-1B or L-1?

Researchers employed under a temporary visa . . . . . . . . . . . . . . . . . . . . .
6-10 In addition to the R&D employees reported in Question 6-1, line a, how many
leased employees and temporary staff, including on-site consultants, worked
in the occupations listed below?
a. Researchers (including
R&D scientists,
engineers, and their
managers) . . . . . . . . . . .

(1)
Domestic Operations

b. R&D technicians and
equivalent staff . . . . . . .
c. R&D support staff
(clerical and other) . . . .
d. Total leased and
temporary employees
working on R&D. . . . .
Form BRD-1

47

(2)
Foreign Operations

(3)

Total leased and temporary
employees working on R&D

SECTION 6

(1)
Domestic Operations

6-11 Who was primarily responsible for completing this section?
Same person mentioned in Question 1-7
Another person ➔ Please provide the following information:
Name

Telephone
Area code

SECTION 6

Title

Form BRD-1

48

Number

Extension

SECTION 7
Intellectual Property and Technology Transfer
Who should answer this section?
Persons with an understanding of your company’s general business strategy and knowledge of its
patenting, licensing, and other activities related to intellectual property should complete this section.
What does this section cover?
This section requests information about your company’s worldwide intellectual property and technology
transfer activities such as: patents, patent licensing, protection of intellectual property, and transfer of
intellectual property.
Are responses to this survey confidential?
Yes. Your responses are completely confidential under Title 13, United States Code, Section 9, and
can only be used to produce statistics. The Census Bureau is not permitted to publicly release your
responses in a way that could identify your business. The law also provides that copies of reports
retained in your files are immune from legal process. In addition, reported data are exempt from
requests made under the Freedom of Information Act.

Total patents and utility patents
Number

7-1

How many total patents did your company apply for in 2023 from
the U.S. Patent and Trademark Office (USPTO)?

7-2

Of the patent applications reported in Question 7-1, what was the
number of nonprovisional utility patent applications?

7-3

What percentage of the nonprovisional utility patent applications
reported in Question 7-2 has your company applied for or plans to
apply for in foreign jurisdictions?

%

7-4

What percentage of the nonprovisional utility patent applications
reported in Question 7-2 was for inventions that originated within
your company’s organized R&D activities?

%

7-5

What percentage of your company’s inventions considered for
patenting in 2023 resulted in nonprovisional utility patent applications?

%

7-6

How many utility patents were issued to your company in 2023 by
the USPTO?

Form BRD-1

49

Number

SECTION 7

Number

Utility patent sales and licensing to others
$Bil.

Mil.

Thou.

$Bil.

Mil.

Thou.

7-7

How much revenue did your company receive
in 2023 from the sale of utility patents?

7-8

How much revenue did your company receive
in 2023 from utility patent licensing?

7-9

Was any of the revenue reported in Questions 7-7
or 7-8 received from companies or organizations
located outside the United States? . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Yes

No

Utility patent purchases and licensing from others
$Bil.

Mil.

Thou.

$Bil.

Mil.

Thou.

7-10 How much did your company pay others in 2023
to purchase utility patents?

7-11 How much did your company pay others in 2023
to license utility patents?

7-12 Were any of the payments reported in Questions 7-10
or 7-11 made to companies or organizations located
outside the United States? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Yes

No

Yes

No

Yes

No

c. Transferred IP to a spin-off or spin-out of your company . . . . . . . . . . . .

Yes

No

d. Received IP from a parent company as part of a spin-off or spin-out . . .

Yes

No

Yes

No

Yes

No

Yes

No

Yes

No

Yes

No

Intellectual property transfer activities
7-13 Did your company perform the following activities in 2023?

SECTION 7

a. Transferred intellectual property (IP) to others not owned by your
company through participation in technical assistance or
"know how" agreements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
b. Received IP from others not owned by your company through
participation in technical assistance or "know how" agreements. . . . . . .

e. Acquired more than 50% ownership in another company for the
primary purpose of acquiring their IP . . . . . . . . . . . . . . . . . . . . . . . . . . .
f. Acquired any financial interest in another company in order to
gain access to their IP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
g. Participated in cross-licensing agreements — the agreements in
which two or more parties grant a license to each other for the
use of the subject matter claimed in one or more of the patents
owned by each party. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
h. Allowed free use of patents or other IP owned by your company
(for example, open source software) . . . . . . . . . . . . . . . . . . . . . . . . . . .
i. Made use of open source patents or other freely available IP not
owned by your company . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Form BRD-1

50

Intellectual property protection
7-14 During 2023, how important to your company were the
following types of intellectual property protection?

Very
important

Somewhat
important

Not
important

a. Utility patents (patents for invention) . . . . . . . . . . . . . . . . . . . .
b. Design patents (patents for appearance). . . . . . . . . . . . . . . . . .
c. Trademarks. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
d. Copyrights . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
e. Trade secrets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
f. Mask works (copyright protection for semiconductor products)

7-15 Who was primarily responsible for completing this section?
Same person mentioned in Question 1-7
Another person ➔ Please provide the following information:
Name

Telephone
Area code

Number

Extension

SECTION 7

Title

Form BRD-1

51

SECTION 8
Tax Topics
Who should answer this section?
Persons familiar with your company’s tax filings.
What does this section cover?
This section requests information about state and federal tax credits for which your company may
have filed.
Are responses to this survey confidential?
Yes. Your responses are completely confidential under Title 13, United States Code, Section 9, and
can only be used to produce statistics. The Census Bureau is not permitted to publicly release your
responses in a way that could identify your business. The law also provides that copies of reports
retained in your files are immune from legal process. In addition, reported data are exempt from
requests made under the Freedom of Information Act.

8-1

Did your company file for the tax credit for increasing
research activities (IRS Form 6765) in 2023? . . . . . . . . . . . . . . . . . . . .

Yes

No

8-2

Did your company file for any U.S. state tax credit for
research activities in 2023? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Yes

No

8-3

Was your company charged for R&D performed by foreign
subsidiaries in 2023 as part of any cost sharing arrangement? . . . .

Yes

No

8-4

Did your company charge foreign subsidiaries for R&D
your company performed in 2023 as part of any cost sharing
arrangement? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Yes

No

8-5

Who was primarily responsible for completing this section?
Same person mentioned in Question 1-7
Another person ➔ Please provide the following information:

Telephone
Title

Area code

Form BRD-1

52

Number

Extension

SECTION 8

Name

Business codes

Consumer Goods
33333 Digital cameras manufacturing
33430 Audio and video equipment manufacturing
31210 Beverage manufacturing
33200 Fabricated metal products manufacturing
31100 Food manufacturing
33700 Furniture and related products manufacturing
32300 Printing and related support activities
32591 Soap, cleaning compound, and toilet
preparations manufacturing
31990 Textile, apparel, and leather products
manufacturing
31220 Tobacco manufacturing
33990 Miscellaneous manufacturing not listed
elsewhere (games, office supplies,
slot machines, etc.)

(used in Sections 1, 2, and 3)
Aerospace and Defense
33642 Aircraft engine and engine parts manufacturing
33641 Aircraft manufacturing
33644 Guided missiles, space vehicles, and parts
manufacturing
33692 Military armored vehicle, tank, and tank
components manufacturing
33452 Search, detection, navigation, guidance,
aeronautical, and nautical system and
instruments manufacturing
33660 Ship and boat building
33643 Other aircraft parts and auxiliary equipment
manufacturing
Automobiles, Motorcycles, and Components
33620 Motor vehicle body and trailer manufacturing
33630 Motor vehicle parts manufacturing
33610 Motor vehicles manufacturing
33691 Motorcycle, bicycle, and parts manufacturing
33651 Railroad rolling stock manufacturing
33660 Ship and boat building
33699 All other transportation equipment
manufacturing

Energy and Mining
33360 Engine, turbine, and power transmission
equipment manufacturing
21200 Mining
33319 Mining, oil, and gas field machinery and
equipment manufacturing
21100 Oil and gas extraction
32401 Petroleum refineries
21300 Support activities for mining,
including oil and gas

Capital Equipment
33311 Agricultural machinery and equipment
manufacturing
33332 Commercial, service industry, temperature
control, and airfiow control machinery
manufacturing
33312 Construction machinery manufacturing
33500 Electrical equipment, appliances, and
components manufacturing
33360 Engine, turbine, and power transmission
equipment manufacturing
33322 Industrial machinery manufacturing, except
semiconductor machinery
33390 Metalworking and other general purpose
machinery manufacturing
33319 Mining, oil, and gas field machinery and
equipment manufacturing
33331 Photographic and photocopying equipment
manufacturing

Finance, Insurance, and Real Estate
52200 Finance: banking and credit intermediation
52400 Insurance carriers and related activities
53100 Real estate
52310 Securities, commodity contracts, and other
financial investments and related activities
(including funds and trusts)
Healthcare
32543 Biotechnology-based pharmaceutical and
biological products (except diagnostics)
33451 Electromedical, electrotherapeutic, and
irradiation apparatus manufacturing
62200 Hospitals and nursing care facilities
32542 In vitro diagnostic substances manufacturing
62150 Medical and diagnostic laboratories
33910 Medical equipment and supplies manufacturing
62110 Offices of physicians
32541 Pharmaceutical, medicinal, and botanical
products manufacturing
54173 Research and development services
in biotechnology (except nanotechnology)
54175 Research and development services in
nanotechnology
54174 Research and development services
in physical, engineering, and life sciences
(except nanotechnology and biotechnology)
62199 Other ambulatory health care services
(ambulance, dental, home health care)

Chemicals and Materials
32402 Asphalt paving, roofing, and saturated
materials manufacturing
32510 Basic chemicals manufacturing
32790 Cement, concrete, lime, gypsum, and other
nonmetallic mineral product manufacturing
32710 Clay and glass products manufacturing
21200 Mining
32592 Paint, adhesive, and other chemical
manufacturing
32200 Paper manufacturing
32530 Pesticide, fertilizer, and other agricultural
chemical manufacturing
32600 Plastics and rubber products manufacturing
33100 Primary metal manufacturing
32520 Resin, synthetic rubber, and artificial
synthetic fibers and filaments manufacturing
32591 Soap, cleaning compound, and toilet
preparations manufacturing
32100 Wood products manufacturing
32403 Other petroleum and coal products
manufacturing, including motor oil,
hydraulic fiuid, and charcoal
Form BRD-1

53

Other
72000
56100
71000
23000
49200

Information Technology - Goods and Services
33333 Digital cameras manufacturing
51801 Cloud computing applications and internet
based software services
54150 Computer systems design and related services
33412 Computers and peripheral equipment
manufacturing, including magnetic and
optical media
51800 Data processing, hosting, and related services
33500 Electrical equipment, appliances, and
components manufacturing
45411 Electronic shopping and mail-order houses
33459 Measuring and control instruments
manufacturing (not listed elsewhere)
33422 Radio, television, and wireless
communication equipment manufacturing
33440 Semiconductor and other electronic
components manufacturing
33321 Semiconductor machinery manufacturing
51120 Software publishers (except Internet)
33421 Telephone apparatus manufacturing
including routers, modems, and gateways
42500 Wholesale electronic markets and
agents and brokers (business to business)
33429 Other communication equipment
manufacturing (except radio, television,
and wireless communication equipment)
51910 Other information services, including
Internet publishing, broadcasting,
and web search portals

53300
55100
42300
42400
51200
51110
53200
44000
62400
21300
48000
49300
81000

Professional, Scientific, and Technical Services
54180 Advertising and related services
54130 Architectural, engineering, and related services
54150 Computer systems design and related services
54111 Legal, accounting, tax preparation,
bookkeeping and payroll services
54160 Management, scientific, and
technical consulting services
54190 Professional, scientific, and technical services
(not listed elsewhere)
54173 Research and development services in
biotechnology (except nanotechnology)
54175 Research and development services in
nanotechnology
54174 Research and development services in
physical, engineering, and life sciences
(except nanotechnology and biotechnology)
54172 Research and development services in
social sciences and humanities
54140 Specialized design services
Telecommunications and Utilities
51500 Broadcasting (except Internet)
51740 Satellite telecommunications
22100 Utilities
56200 Waste management and remediation services
51710 Wired telecommunications carriers
51720 Wireless telecommunications carriers
(except satellite)
51790 Other telecommunications (not listed elsewhere)

Form BRD-1

54

Services
Accommodation and food services
Administrative and support services
Arts, entertainment, and recreation
Construction
Couriers, messengers, and express delivery
services
Lessors of nonfinancial intangible assets
(including patent licensing)
Management of companies and enterprises
Merchant wholesalers, durable goods
Merchant wholesalers, nondurable goods
Motion picture and sound recording
(except Internet)
Newspaper, periodical, book, and
directory publishers (except Internet)
Rental and leasing services
Retail trade, except electronic shopping
and mail-order houses
Social assistance services
Support activities for mining,
including oil and gas
Transportation
Warehousing and storage
Other services (not listed elsewhere)

This page intentionally left blank

Form BRD-1

55

Hours

Approximately how long did it take to complete this survey?

Minutes

:

Remarks (Please use this space below for any explanations that may be essential in understanding your
reported data.)

Thank You – Your Response is Important
Accurate and timely statistical information could not be produced without your continued cooperation
and goodwill. Thank you.
We estimate this survey will take between 15 minutes and 18 hours, with an average of 2 hours and 37
minutes to complete, including the time for reviewing instructions, searching existing data sources,
gathering and maintaining the data needed, and completing and reviewing the collection of information.
You may email comments regarding this burden estimate or any other aspect of this collection of
information, including suggestions for reducing this burden, to [email protected]. Be sure
to use "ERD Survey Comments 0607-0912" as the subject.
Form BRD-1

56